|
Company
Roster
|
Total
Insiders : |
23 |
|
|
Total
Direct Shares :
|
5,320,420 |
|
Total
Indirect Shares :
|
10,030,500 |
|
%
Held by Insiders:
|
4.2% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Keenan Greg |
Chief Medical Officer |
2025-03-07 |
153,484 |
|
0 |
Donley Matthew Maxwell |
Chief Operating Officer |
2025-03-04 |
680,465 |
2021-05-11 |
0 |
Robertson Stephen P. |
EVP, General Counsel |
2025-03-04 |
509,276 |
2021-01-28 |
0 |
Greenleaf Peter |
Chief Executive Officer, Director |
2025-03-04 |
1,788,945 |
2021-05-11 |
0 |
Miller Joseph M |
Chief Financial Officer |
2025-03-04 |
577,361 |
2021-05-11 |
0 |
Smith Karen L. |
Director |
2024-11-21 |
24,807 |
2024-11-08 |
0 |
Leversage Jill |
Director |
2024-11-21 |
25,053 |
2021-01-29 |
1,000 |
Johnson Craig A |
Director |
2024-11-21 |
20,631 |
2024-11-21 |
0 |
Jayne David R.w. |
Director |
2024-11-21 |
56,499 |
2022-05-18 |
0 |
Bailey Jeffrey Allen |
Director |
2024-11-21 |
25,491 |
2024-11-08 |
0 |
Habig Scott Michael |
Chief Commercial Officer |
2024-08-06 |
456,338 |
2022-11-09 |
0 |
Mackay-Dunn R. Hector |
Director |
2024-05-21 |
18,595 |
2021-05-11 |
0 |
Balakrishnan Brinda |
Director |
2024-05-21 |
17,523 |
2023-05-18 |
0 |
Billen Daniel |
Director |
2024-05-21 |
28,141 |
2023-05-18 |
0 |
Knappertz Volker |
EVP, Research and Development |
2024-02-27 |
319,128 |
2023-03-02 |
0 |
Hagan Joseph P |
Director |
2023-05-19 |
11,961 |
2022-01-03 |
0 |
Milne George M Jr |
Director |
2023-05-18 |
78,733 |
2021-03-05 |
0 |
Martin Michael Robert |
Chief Business Officer |
2023-03-02 |
259,162 |
2021-05-11 |
0 |
Colao Massimilano |
Chief Commercial Officer |
2022-03-02 |
13,495 |
2022-03-02 |
0 |
Solomons Neil |
Chief Medical Officer |
2022-03-02 |
90,953 |
2021-03-12 |
0 |
Huizinga Robert Bindert |
EVP of Research |
2022-03-02 |
69,379 |
2021-05-11 |
0 |
Hayden Michael R |
Director |
2021-01-29 |
95,000 |
2021-01-29 |
0 |
Tang Kevin C |
|
|
0 |
2025-03-04 |
10,029,500 |
|